Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Fullblast

T.VRX

RE:Not great news, shares down after hours

Not sure how they can do that when VRX has until April 29 to file, and they...

April 12, 2016

T.VRX

RE:RE:RE:Valeant to release earnings on April 28th

Tjw4, the PR was released on Saturday. It announces the next earning...

April 11, 2016

T.VRX

RE:Valeant to release earnings on April 28th

Valeant Pharmaceuticals InternationalCorporate Event Announcement Notice 21...

April 11, 2016

T.VRX

Valeant to release earnings on April 28th

Press release is out.

April 11, 2016

T.VRX

Accounting review is done, 10-K is coming

April 5, 2016 /PRNewswire via COMTEX News Network/ -- Valeant Pharmaceuticals...

April 5, 2016

T.VRX

Default is off the table for now

March 30, 2016 /PRNewswire via COMTEX News Network/ -- Intends to File 10-K...

March 30, 2016

T.VRX

RE:Michael Waterhouse, Senior Equity Analyst 3/21/16

This is from an old Morningstar report which came out in november, I believe.

March 28, 2016

T.VRX

RE:This tells all!

Small advice : I've got Paulson and Groupguru on ignore... My board is a...

March 24, 2016

T.VRX

RE:RE:RE:RE:Look to Q2 2016

Groupguru. you don't know me. I bought biovail for 8$ in 2007, before it...

March 18, 2016

T.VRX

Philidor investigation is holding the 10-K

To me, this comment by Parke Shall, on Seeking Alpha, is the most probable...

March 18, 2016

T.VRX

RE:RE:Look to Q2 2016

I agree with you Johnny41

March 18, 2016

T.VRX

Look to Q2 2016

A few week ago, Ackman said that Q4 2015 and Q1 2016 will be "messy"...

March 18, 2016

T.VRX

RE:RE:National Bank has fair value at $155 US, $155 CDN, for VRX

... it's actually morningstar, I'd doubt they have shares.

March 16, 2016

T.VRX

... I mean $115 US... $155 CDN

Sorry.

March 16, 2016

T.VRX

National Bank has fair value at $155 US, $155 CDN, for VRX

We are lowering our fair value estimate for Valeant to $115 per share from...

March 16, 2016

T.VRX

RE:RE:RE:RE:RE:listen to Carl Ichan & George Soros about a market collapse.

Truthseeker, I don't think that you are ignorant or moron. Why do you...

January 11, 2016

T.VRX

RE:RE:RE:listen to Carl Ichan & George Soros about a market collapse.

Truthseeker, I bought biovail in 2007 for $8, which then became Valeant. I...

January 11, 2016

T.VRX

RE:listen to Carl Ichan & George Soros about a market collapse.

Truthseeker, I'm sorry to read that you are not doing well. I hope that...

January 10, 2016

T.VRX

RE:guys this one is going down even if thngs were great

Most financial analysts disagree with you.

January 5, 2016

V.BBI

RE:Why the 10% drop?

Indeed

March 31, 2015

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »